Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Journal of Opioid Management|April 23, 2021
Why we still prescribe so many opioids: A qualitative study on -barriers and facilitators to prescribing guideline implementationKathryn W Zavaleta, Lindsey M Philpot, Julie L Cunningham, et al.
Hospital Practice (1995)|April 7, 2021
Hospitalist perspectives on barriers to recommend and potential benefit of the COVID-19 vaccineSagar B Dugani, Holly L Geyer, Michael J Maniaci, et al.
BMC Cancer|June 11, 2021
Tobacco use in the Myeloproliferative neoplasms: symptom burden, patient opinions, and careSarah F Christensen, Robyn M Scherber, Gina L Mazza, et al.
Leukemia & Lymphoma|January 18, 2019
Item nonresponse on the Myeloproliferative Neoplasms Symptom Assessment Form (MPN-SAF): a comparison of missing data strategiesGina L Mazza, Katie L Kunze, Blake T Langlais, et al.
Mayo Clinic Proceedings|March 16, 2020
An Institutional Approach to Managing the Opioid CrisisHalena M Gazelka, Casey M Clements, Julie L Cunningham, et al.
Cancer|December 17, 2015
Comprehensively understanding fatigue in patients with myeloproliferative neoplasmsRobyn M Scherber, Heidi E Kosiorek, Zhenya Senyak, et al.
PNAS Nexus|July 14, 2022
Durability analysis of the highly effective BNT162b2 vaccine against COVID-19Arjun Puranik, Patrick J Lenehan, John C O'Horo, et al.
PNAS Nexus|January 30, 2023
Durability analysis of the highly effective mRNA-1273 vaccine against COVID-19Arjun Puranik, Patrick J Lenehan, John C O'Horo, et al.
Med (New York, N.Y.)|December 20, 2021
Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infectionArjun Puranik, Patrick J Lenehan, Eli Silvert, et al.
JAMA Network Open|April 14, 2022
Surveillance of Safety of 3 Doses of COVID-19 mRNA Vaccination Using Electronic Health RecordsMichiel J M Niesen, Colin Pawlowski, John C O'Horo, et al.
Pageof 4